drugset / Trial / NCT00990028

Effect of Rosuvastatin on Cytokines After Traumatic Brain Injury

NCT00990028 ↗

RandomizedSingle-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether rosuvastatin could alter the immunological response after head injury by modulating TNF-alpha,IL6,IL-1.

Timeline

Start
2009-08
Primary completion
2011-07
Completion
2011-08

Outcome

Mixed primary results

paper The best-fit mixed model showed a significant effect of rosuvastatin on the reduction of tumor necrosis factor-α levels (p = 0.004). PMID 23289819 ↗

paper Rosuvastatin treatment did not appear to affect the levels of IL-1β, IL-6, and IL-10. PMID 23289819 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 20 mg Oral

Indications